Cargando…
Retracted: miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307228/ https://www.ncbi.nlm.nih.gov/pubmed/37388066 http://dx.doi.org/10.1155/2023/9861015 |
Ejemplares similares
-
Retracted: TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Study on the Mechanism of miR-146a in Gingival Mesenchymal Stem Cells
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: miR-216b-5p Inhibited the Progression of Experimental Optic Neuritis via Downregulating FAS
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9
por: Wang, Qiang, et al.
Publicado: (2021)